OTCMKTS:MBGNF

Med BioGene Stock Forecast, Price & News

$0.12

0.00 (0.00 %)

(As of 09/15/2021 12:00 AM ET)

Add

Compare

Today's Range

$0.12

▼

$0.12

50-Day Range

$0.11

▼

$1.00

52-Week Range

$0.04

▼

$1.00

Volume501 shs

Average Volume5,203 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive MBGNF News and Ratings via Email

Sign-up to receive the latest news and ratings for Med BioGene and its competitors with MarketBeat's FREE daily newsletter.

About Med BioGene

Med BioGene, Inc. operates as a life science company. The firm engages in the development and commercialization of genomic-based clinical laboratory diagnostic tests. It focuses on managing the license and rights for GeneFx Lung, prognostic genomic-based test for non-small-cell lung cancer. The company was founded on April 28, 2006 and is headquartered in Vancouver, Canada.

Med BioGene Inc. (OTCMKTS:MBGNF) Sees Significant Drop in Short Interest
August 27, 2021 | americanbankingnews.com

How Much Are Med BioGene Inc. (CVE:MBI.H) Insiders Spending On Buying Shares?
November 30, 2020 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:MBGNF
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.medbiogene.com
Phone(604) 732-7332
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.93 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Med BioGene.

4.7 Community Rank

Outperform Votes
Med BioGene has received 29 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Med BioGene has received 13 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Med BioGene has received 69.05% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Med BioGene and other stocks. Vote “Outperform” if you believe MBGNF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MBGNF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Med BioGene does not currently pay a dividend.
Dividend Growth
Med BioGene does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Med BioGene insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Med BioGene (OTCMKTS:MBGNF) Frequently Asked Questions

What stocks does MarketBeat like better than Med BioGene?

Wall Street analysts have given Med BioGene a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Med BioGene wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Med BioGene?

Med BioGene saw a decline in short interest in August. As of August 13th, there was short interest totaling 1,000 shares, a decline of 61.5% from the July 29th total of 2,600 shares. Based on an average trading volume of 6,700 shares, the short-interest ratio is currently 0.1 days.
View Med BioGene's Short Interest.

How were Med BioGene's earnings last quarter?

Med BioGene Inc. (OTCMKTS:MBGNF) posted its earnings results on Friday, November, 29th. The company reported ($0.01) earnings per share for the quarter.
View Med BioGene's earnings history.

How has Med BioGene's stock price been impacted by Coronavirus?

Med BioGene's stock was trading at $0.04 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MBGNF shares have increased by 202.8% and is now trading at $0.1211.
View which stocks have been most impacted by COVID-19.

Who are Med BioGene's key executives?

Med BioGene's management team includes the following people:

Iain Weir-Jones, Chairman & Chief Executive Officer
Ibrahim Ghobrial, Chief Financial Officer & Secretary

Who are some of Med BioGene's key competitors?

Some companies that are related to Med BioGene include Australian Clinical Labs (ACL), BARD1 Life Sciences (BD1), Biomark Diagnostics (BUX), Charles River Laboratories International (CRL), Cryosite (CTE), dorsaVi (DVL), Epigenomics (EPGNY), Eternity Healthcare (ETAH), Genetic Signatures (GSS), Genetic Technologies (GTG), Imagin Medical (IME), Imagion Biosystems (IBX), Integral Diagnostics (IDX), Lifespot Health (LSH) and Medical Imaging (MEDD).
View all of MBGNF's competitors.

What is Med BioGene's stock symbol?

Med BioGene trades on the OTCMKTS under the ticker symbol "MBGNF."

How do I buy shares of Med BioGene?

Shares of MBGNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Med BioGene's stock price today?

One share of MBGNF stock can currently be purchased for approximately $0.12.

What is Med BioGene's official website?

The official website for Med BioGene is www.medbiogene.com.

Where are Med BioGene's headquarters?

Med BioGene is headquartered at 598 East Kent Avenue South, Vancouver, BC V5X.

How can I contact Med BioGene?

Med BioGene's mailing address is 598 East Kent Avenue South, Vancouver, BC V5X. The company can be reached via phone at (604) 732-7332.

This page was last updated on 9/16/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Med BioGene Stock Forecast, Price & News

About Med BioGene

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

4.7 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment